⌕
Quest Diagnostics · DGX · NYSE
Tenet 47 · Mixed
Compare
$262.21+1.01%At closeTenet 47 · Mixed
$262.21+2.61 (+1.01%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
$261.25−0.96 (−0.37%)
After hours: Nov 16, 2026, 7:29 PM ET

Quest Diagnostics (DGX) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Zacks Investment ResearchNov 12, 2026 · 10:41 ET
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.…

● PRNewsWireNov 10, 2026 · 16:06 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 4
Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J., Nov. 10, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 …

● PRNewsWireNov 9, 2026 · 12:40 ETCOMPANY'S OWN WORDS
Quest Diagnostics to Speak at the 9th Annual Evercore Healthcare Conference

SECAUCUS, N.J., Nov. 9, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will p…

● PRNewsWireNov 9, 2026 · 12:39 ETCOMPANY'S OWN WORDS
Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference in London

SECAUCUS, N.J., Nov. 9, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will p…

● Zacks Investment ResearchOct 27, 2026 · 10:41 ET
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

● Seeking AlphaOct 26, 2026 · 22:53 ETEARNINGS EXPECTED BY FEB 4
Quest Diagnostics Upgraded After Strong Q3, While Also Announcing New Test For Alzheimer's

Quest Diagnostics is upgraded to a strong buy, driven by robust earnings momentum, sector resilience, and sustained outperformance versus benchmarks. DGX delivered its fourth consecutive earnings beat, with Q3 revenue up…

● Defense WorldOct 26, 2026 · 05:05 ETEARNINGS EXPECTED BY FEB 4
Quest Diagnostics Incorporated $DGX Stock: Yousif Capital Management LLC Raises Holdings

Yousif Capital Management LLC lifted its stake in Quest Diagnostics Incorporated (NYSE: DGX) by 67.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The i…

● Business WireOct 23, 2026 · 16:33 ET
PRIVACY ALERT: AWKO Law LLP Investigates Quest Diagnostics for Data Breach of Patient Records

SAN FRANCISCO--(BUSINESS WIRE)--AWKO Law LLP is investigating a data breach that led to unauthorized access to the sensitive information of patients of Quest Diagnostics, a New Jersey-based diagnostic testing company. Qu…

● TechCrunchOct 23, 2026 · 11:00 ET
Lab testing giant Quest Diagnostics confirms patients' personal and health data was compromised during breach

Medical lab testing giant Quest Diagnostics has confirmed a cyberattack and data breach affecting an as-yet unspecified amount of sensitive patient information stored in its systems, according to a legally required discl…

● Zacks Investment ResearchOct 23, 2026 · 10:50 ET
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.…

● Zacks Investment ResearchOct 22, 2026 · 15:21 ETEARNINGS EXPECTED BY FEB 4
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market

Quest Diagnostics beats Q3 earnings and revenue estimates, raises its 2026 outlook on strong testing demand and margin gains, yet shares dip in pre-market trading.…

● MarketBeatOct 22, 2026 · 14:06 ETEARNINGS EXPECTED BY FEB 4
What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call

Quest Diagnostics NYSE: DGX reported third-quarter 2026 revenue growth of 10% and adjusted earnings-per-share growth of more than 15%, citing demand across its physician, hospital and consumer channels as well as product…

● The Motley FoolOct 22, 2026 · 14:04 ETEARNINGS EXPECTED BY FEB 4
Quest Diagnostics: 3 Key Takeaways for Long-Term Investors

Quest Diagnostics expects consumer health revenue growth to exceed 30% in 2026. Organic requisition volume increased 14.4% in the third quarter of 2026.…

● Seeking AlphaOct 22, 2026 · 13:27 ETEARNINGS EXPECTED BY FEB 4
Quest Diagnostics Incorporated (DGX) Q3 2026 Earnings Call Transcript

Quest Diagnostics Incorporated (DGX) Q3 2026 Earnings Call Transcript…

● BenzingaOct 22, 2026 · 12:49 ETEARNINGS EXPECTED BY FEB 4
Quest Diagnostics Bumps Guidance While Managing Quanum System Breach

Quest Diagnostics Incorporated (NYSE:DGX) on Thursday reported third-quarter adjusted earnings of $3 per share, beating the Wall Street estimate of $2.86.…

● Zacks Investment ResearchOct 22, 2026 · 09:00 ETEARNINGS EXPECTED BY FEB 4
Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates

Quest Diagnostics (DGX) came out with quarterly earnings of $3 per share, beating the Zacks Consensus Estimate of $2.85 per share. This compares to earnings of $2.6 per share a year ago.…

● PRNewsWireOct 22, 2026 · 06:46 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 4
Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

Third quarter revenues of $3.10 billion, up 10.0% from 2025, on strong organic revenue growth Third quarter reported diluted earnings per share ("EPS") of $2.78, up 28.7% from 2025; and adjusted diluted EPS of $3.00, up …

● PRNewsWireOct 20, 2026 · 08:00 ET
Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option

Expands access to most comprehensive FDA-approved HPV test and at-home self-collection option across Quest's national clinician, health plan, and consumer channels starting in 2027 First and only FDA-approved HPV test th…

● Fast CompanyOct 20, 2026 · 07:32 ET
A new at-home HPV test kit is going national through Quest Diagnostics

Patients across the U.S. will soon have access to a new cervical cancer test collected from the comfort of their own home—no stirrups, speculum, or in-person doctor's visit needed.…

● Defense WorldOct 18, 2026 · 02:15 ETEARNINGS EXPECTED BY FEB 4
Critical Review: Quest Diagnostics (NYSE:DGX) & Cigna Group (NYSE:CI)

Cigna Group (NYSE: CI - Get Free Report) and Quest Diagnostics (NYSE: DGX - Get Free Report) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the …

● Defense WorldOct 16, 2026 · 02:59 ETEARNINGS EXPECTED BY FEB 4
Analyzing Mangoceuticals (NASDAQ:MGRX) & Quest Diagnostics (NYSE:DGX)

Quest Diagnostics (NYSE: DGX - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the stre…

● Zacks Investment ResearchOct 14, 2026 · 10:16 ETEARNINGS EXPECTED BY FEB 4
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings

DGX heads into Q3 earnings with expected revenue and EPS growth, fueled by strong clinical demand, advanced diagnostics and operational efficiencies.…

● PRNewsWireSep 22, 2026 · 16:28 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 4
Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026

SECAUCUS, N.J., Sept. 22, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its third quarter 2026 financial results on Thur…

● PRNewsWireSep 21, 2026 · 08:03 ET
Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics

Study published in JAMA Network Open of over 193,000 patients nationwide reveals that individuals with evidence of exposure to Borrelia burgdorferi, the bacterium that causes Lyme disease, are more than four times as lik…

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 4. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Article counts from the last market-wide feed page, across every symbol we track and not just DGX · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.